Form EFFECT Chemomab Therapeutics
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | May 17, 2021 4:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Chemomab Therapeutics to Report First Quarter 2024 Financial Results and Provide a Business Update
- Akanda Appoints Cooper to the Board of Directors
- TotalEnergies BWF Thomas & Uber Cup Finals 2024 to Kick Off in Chengdu
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
